Related Experiment Video
Updated: Dec 22, 2025

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
CREBBP gene mutation in an infant with Rubinstein-Taybi syndrome
Jie Shen1, Mingyi Zhao1, Zhihui Zeng2
1Department of Pediatrics, Third Xiangya Hospital, Central South University, Changsha 410013, China yunhojie@163.com.
Insights
Rubinstein-Taybi syndrome (RSTS) is a rare genetic disorder characterized by distinctive facial features and developmental delays. A new case identified a de novo CREBBP gene mutation, highlighting the genetic basis of this condition.
Area of Science:
- Genetics
- Pediatrics
- Medical Case Reports
Background:
- Rubinstein-Taybi syndrome (RSTS) is a rare autosomal dominant genetic disorder.
- Key features include craniofacial dysmorphisms, skeletal malformations, and developmental delays.
- Currently, effective therapies for RSTS are limited.
Abstract:
Rubinstein-Taybi syndrome (RSTS), also known as broad thumb-great toe syndrome or broad digits syndrome, is a rare autosomal dominant genetic disease. The main features of the patients are craniofacial dysmorphisms, skeletal malformations, and delay of growth and psychomotor development. In this case, the child has a typical RSTS specific face and growth retardation, with atypical indirect inguinalhemia. A heterozygous mutation, C. 4492 C>T (p. Arg1498Ter), was found in the exon of CREBBP gene by gene sequencing. It was a nonsense mutation, which leads to the premature termination of peptide synthesis. The mutation was not observed in the child's parents, which may be a de Novo mutation. The disease is lack of effective therapy so far.
More Related Videos
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Pedigree Analysis
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...

